Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Lignende værker

• Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
  af: Fava, Maurizio, et al.
  Udgivet: (2018)
• Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
  af: Yatham, Lakshmi N., et al.
  Udgivet: (2020)
• Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study
  af: Earley, Willie R., et al.
  Udgivet: (2019)
• SU14. Characteristics Associated With Relapse in Patients With Schizophrenia: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Cariprazine Relapse Prevention Trial
  af: Kunovac, Jelena, et al.
  Udgivet: (2017)
• Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
  af: Vieta, Eduard, et al.
  Udgivet: (2019)